Quarry LP bought a new position in shares of Molina Healthcare, Inc. (NYSE:MOH – Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 576 shares of the company’s stock, valued at approximately $171,000.
Several other institutional investors have also modified their holdings of the business. Algert Global LLC bought a new position in shares of Molina Healthcare during the 2nd quarter valued at about $211,000. Scientech Research LLC bought a new position in shares of Molina Healthcare during the 2nd quarter valued at about $2,448,000. Scion Asset Management LLC bought a new position in shares of Molina Healthcare during the 2nd quarter valued at about $7,293,000. Mackenzie Financial Corp lifted its holdings in shares of Molina Healthcare by 22.1% during the 2nd quarter. Mackenzie Financial Corp now owns 7,641 shares of the company’s stock valued at $2,272,000 after purchasing an additional 1,384 shares in the last quarter. Finally, Maverick Capital Ltd. lifted its holdings in shares of Molina Healthcare by 404.1% during the 2nd quarter. Maverick Capital Ltd. now owns 5,863 shares of the company’s stock valued at $1,743,000 after purchasing an additional 4,700 shares in the last quarter. Institutional investors own 98.50% of the company’s stock.
Molina Healthcare Stock Up 0.8 %
NYSE:MOH opened at $344.56 on Tuesday. The firm has a market capitalization of $20.19 billion, a price-to-earnings ratio of 18.70, a price-to-earnings-growth ratio of 1.21 and a beta of 0.57. Molina Healthcare, Inc. has a twelve month low of $282.96 and a twelve month high of $423.92. The stock’s 50 day moving average price is $340.66 and its two-hundred day moving average price is $340.88. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49.
Insider Buying and Selling
In related news, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on MOH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a report on Tuesday, September 10th. JPMorgan Chase & Co. cut their price objective on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a report on Wednesday, July 10th. TD Cowen cut their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating on the stock in a research note on Wednesday, July 24th. Jefferies Financial Group cut their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research note on Wednesday, July 24th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating on the stock in a research note on Monday, July 29th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and an average target price of $378.00.
Get Our Latest Stock Report on MOH
Molina Healthcare Company Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
- Five stocks we like better than Molina Healthcare
- What Are Dividend Champions? How to Invest in the Champions
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- What is Insider Trading? What You Can Learn from Insider Trading
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- How to Calculate Stock Profit
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.